Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thymosin alpha 1 (Tα1) is a naturally occurring 28-amino acid peptide originally isolated from the thymus gland. It plays a crucial role in modulating, enhancing, and restoring immune function. Tα1 acts as an agonist on several Toll-like receptors (TLRs), stimulating both innate and adaptive immunity. It increases the production of cytokines and promotes the maturation/activation of various immune cells. Tα1 has demonstrated efficacy or potential benefit in viral infections, cancer, immune deficiencies, autoimmune diseases, and as a vaccine adjuvant. Synthetic analogues like thymalfasin are available clinically and are generally well-tolerated.
Agonist of Toll-like receptors (TLRs), including TLR2, TLR3, TLR4, TLR7, and TLR9. Induces cytokine production (IL-2, IL-6, IL-10, IL-12, IFN-α/γ) and reduces pro-inflammatory cytokines (TNF-alpha, IL-1β). Promotes maturation/activation of CD4+ and CD8+ T lymphocytes; enhances natural killer cell activity; supports B cell differentiation; prevents apoptosis in various immune cells.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thymosin Alpha 1 (Tα1).